CASTLE BIOSCIENCES INC
For the period ended May 5, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 5, 2025 · Filed May 5, 2025
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| NET REVENUES | $87,988 | $72,974 |
| OPERATING EXPENSES | ||
| Cost of sales (exclusive of amortization of acquired intangible assets) | 16,383 | 13,894 |
| Research and development | 12,588 | 13,809 |
| Selling, general and administrative | 58,620 | 48,495 |
| Amortization of acquired intangible assets | 28,325 | 2,247 |
| Total operating expenses, net | 115,916 | 78,445 |
| Operating loss | (27,928) | (5,471) |
| Interest income | 3,099 | 2,996 |
| Changes in fair value of trading securities | (1,425) | — |
| Interest expense | (17) | (14) |
| Loss before income taxes | (26,271) | (2,489) |
| Income tax (benefit) expense | (423) | 45 |
| Net loss | $(25,848) | $(2,534) |
| Loss per share, basic and diluted | $(0.90) | $(0.09) |
| Weighted-average shares outstanding, basic and diluted | 28,609 | 27,485 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.